I'm just an ole country boy speculating here but from my understanding the 90 day trials are to test for safety and dosage. After that evaluate how to proceed with next phase which is clinical trials on people with staph. Dosage amounts and timing. I don't think this is the researchers first day on the job so I trust they know what they are doing. After we know the outcome no more speculating on 1b and stock price goes up or down. I think good results will come out so I a buyer here. The spec part of this equation keeps this stock price down because of the unknown fear factor. It's not for everybody. So if you can't take the heat get out of the kitchen and let the doctors do the cooking. I'd like to get some more cheap shares. Brock in Ar